An addendum to these studies is that in non-small cell lung cancers in female patients from China (Beijing hospital), MDM2 protein levels were identified by immunohistochemistry to be at higher levels both in the cytoplasm and nucleus, compared with lower levels and nuclear location in the cancer adjacent tissues. This evidence concerns the gene MDM2 and non-small cell lung carcinoma.